story of the week
GLP-1 Receptor Agonists and SGLT2 Inhibitors for Treatment of Diabetes in Liver Transplant Recipients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
Diabetes Obes Metab 2024 Jul 26;[EPub Ahead of Print], K Zheng, A Azhie, X You, M Naghibzadeh, E Tan, S Naimimohasses, VS Sridhar, S Gupta, S Chen, S Dash, C Tsien, N Selzner, L Lilly, E Jaeckel, M Woo, S Singh, D Cherney, M BhatFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.